Physician profile
Constantine Economus
NPI 1730170432
$7,142.47
in general payments reported to CMS, 2019-2025
45 companies · $742 in 2025
The $742 reported for 2025 was more than what 88% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $390 · 2020: $496 · 2021: $798 · 2022: $1,064 · 2023: $2,999 · 2024: $653 · 2025: $742.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,294 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,294.29 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lumenis Be INC | $1,905.74 | 2023 | M22 |
| Mayne Pharma Commercial LLC | $958.32 | 2021-2025 | |
| Amgen INC. | $351.10 | 2019-2025 | Evenity, Prolia, Prolia |
| Abbvie INC. | $344.48 | 2019-2023 | Lo Loestrin Fe, Orilissa |
| Myovant Sciences INC. | $284.10 | 2021-2022 | |
| Gynesonics, INC. | $280.07 | 2021-2022 | |
| Therapeuticsmd, INC. | $277.30 | 2019-2022 | |
| Agile Therapeutics, INC. | $276.41 | 2021-2024 | Twirla |
| Sage Therapeutics, LLC | $262.08 | 2024-2025 | Zurzuvae |
| Corcept Therapeutics | $242.24 | 2023-2025 | Korlym |
| Astellas Pharma US INC | $171.05 | 2023-2024 | Veozah |
| Hologic Sales and Service, LLC | $144.87 | 2019-2024 | Acessa Provu System, Myosure Tissue Removal Device |
| Sumitomo Pharma America, INC. | $118.04 | 2023-2024 | Myfembree, Gemtesa |
| Aspira Women'S Health INC | $115.99 | 2022 | |
| Evofem Biosciences, INC. | $113.69 | 2020-2022 |
Show all 45 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $105.84 | 2023-2024 | |
| Organon LLC | $105.25 | 2023-2025 | Nexplanon, Jada System |
| Coopersurgical, INC. | $101.60 | 2019-2022 | |
| Janssen Pharmaceuticals, INC | $98.03 | 2019-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $78.14 | 2025 | |
| Avion Pharmaceuticals | $69.96 | 2019-2022 | |
| Supernus Pharmaceuticals, INC. | $68.14 | 2025 | Qelbree |
| Allergan, INC. | $57.19 | 2019-2020 | |
| Novo Nordisk INC | $54.68 | 2019-2020 | |
| Glaxosmithkline, LLC. | $54.03 | 2019-2025 | Trelegy Ellipta |
| Minerva Surgical, INC | $45.80 | 2020-2024 | |
| Exact Sciences Corporation | $45.13 | 2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Lupin INC. | $45.07 | 2019-2020 | |
| Meditrina | $41.20 | 2023-2024 | |
| Dilon Technologies, INC. | $34.97 | 2023-2024 | Hemoblast Bellows |
| Radius Health, INC. | $32.94 | 2020-2021 | |
| Becton, Dickinson and Company | $27.90 | 2019-2020 | |
| Currax Pharmaceuticals LLC | $27.80 | 2023 | Contrave, Onzetra Xsail |
| Conmed Corporation | $26.91 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $22.55 | 2020-2021 | |
| Mycovia Pharmaceuticals, INC. | $20.00 | 2023 | Vivjoa |
| Si-Bone, INC. | $19.22 | 2023 | |
| Sanofi Pasteur INC. | $18.10 | 2024 | |
| Shield Therapeutics INC | $17.03 | 2023 | Accrufer |
| Exeltis, USA INC. | $15.28 | 2021 | |
| Boston Scientific Corporation | $14.37 | 2019 | |
| Vertex Pharmaceuticals Incorporated | $13.71 | 2025 | |
| Ethicon US, LLC | $13.29 | 2023 | Ethicon |
| Lilly USA, LLC | $11.64 | 2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $11.22 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Constantine Economus listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.